Brief: Anika Therapeutics Q2 Adjusted Loss Per Share $0.12
03/08/2022 22:46
Anika Therapeutics Inc ANIK.O :
* ANIKA REPORTS SECOND QUARTER FISCAL 2022 FINANCIAL RESULTS
* Q2 ADJUSTED LOSS PER SHARE $0.12
* Q2 LOSS PER SHARE $0.20
* REVENUE IN Q2 OF 2022 WAS $39.7 MILLION, UP 4%
Source text for Eikon: ID:nGNX3FdNfQ
Further company coverage: ANIK.O
Recent news on Anika Therapeutics
See all newsAnika Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Anika Therapeutics Q2 revenue rises, lifts 2026 outlook
Anika Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Anika Therapeutics Enters Fifth Amendment To Credit Agreement - SEC Filing
Anika Therapeutics Q1 revenue rises 13%